EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Should Injectable Meloxicam Be Approved for Use in Cats?

Matthew K Wun iD, Michael H Court iD, Nicolas F Villarino iD, Richard Malik iD

Journal of Veterinary Pharmacology and Therapeutics · 2026-03 · 49 (2) · 228-230

DOI: 10.1111/jvp.70060 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Veterinary Pharmacology and Therapeutics, online erschienen am 08.03.2026. Verfasst von Matthew K Wun und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Veterinary Clinical Sciences, College of Veterinary Medicine, Washington State University, Pullman, Washington, USA. Hauptthemen laut MEDLINE: Anti-Inflammatory Agents, Non-Steroidal, Cat Diseases, Drug Approval. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 18 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Injectable meloxicam remains widely used in feline practice despite its association with acute kidney injury (AKI). Evidence of this association was apparent in the results of a clinical trial submitted to the U.S. Food and Drug Administration as part of a New Animal Drug Application (NADA) Freedom of Information Summary. These data, however, were omitted from the published version of that clinical trial in the Journal of the American Veterinary Medical Association (JAVMA). The study's financial sponsorship by the drug manufacturer raises ethical concerns, especially given meloxicam's ongoing and enthusiastic promotion by veterinary organizations also financially supported by the manufacturer. This viewpoint questions meloxicam's approval process and highlights the potential influence of pharmaceutical industry sponsorship on veterinary prescribing practices and policy.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Anti-Inflammatory Agents, Non-SteroidalCat DiseasesDrug ApprovalAnimalsCatsMeloxicamUnited StatesInjectionsAcute Kidney Injury

Stichwörter der Autor:innen

NSAIDacute kidney injuryadverse drug reactionsresearch integrity

Substanzen

MeloxicamAnti-Inflammatory Agents, Non-Steroidal

Autor:innen und Institutionen

  • Department of Veterinary Clinical Sciences, College of Veterinary Medicine, Washington State University, Pullman, Washington, USA.
  • Department of Pharmacology and Toxicology, College of Pharmacy, University of Arizona, Tucson, Arizona, USA.
  • VetMED, Emergency & Specialty Veterinary Hospital, Phoenix, Arizona, USA.
  • Centre for Veterinary Education, The University of Sydney, Camperdown, New South Wales, Australia.

ORCID-Profile: Matthew K Wun, Michael H Court, Nicolas F Villarino, Richard Malik

Zitieren

APA

Wun, M. K., Court, M. H., Villarino, N. F., & Malik, R. (2026). Should Injectable Meloxicam Be Approved for Use in Cats?. Journal of Veterinary Pharmacology and Therapeutics, 49(2), 228-230. https://doi.org/10.1111/jvp.70060

Vancouver

Wun MK, Court MH, Villarino NF, Malik R. Should Injectable Meloxicam Be Approved for Use in Cats?. Journal of Veterinary Pharmacology and Therapeutics. 2026;49(2):228-230. doi:10.1111/jvp.70060

BibTeX
@article{Wun2026,
  author = {Wun, Matthew K and Court, Michael H and Villarino, Nicolas F and Malik, Richard},
  title = {Should Injectable Meloxicam Be Approved for Use in Cats?},
  journal = {Journal of Veterinary Pharmacology and Therapeutics},
  year = {2026},
  volume = {49},
  number = {2},
  pages = {228--230},
  doi = {10.1111/jvp.70060}
}
Kostenlos starten →